Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

KHN’s ‘What the Health?’: Paging the HHS Secretary

by Medical Finance
in Coronavirus
New tool could help detect geographical hotspots for mental health problems caused by COVID
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Health and Human Services Secretary Xavier Becerra is becoming a target for both Democrats and Republicans over what they call a lack of coordination of covid efforts within his department. But at the same time, officials from the Biden administration have made it clear from the start that the covid campaign would be orchestrated by the White House, so it’s not clear whether the secretary was supposed to play a major role.

Meanwhile, as covid cases decline, covid-weary politicians and the public are pushing to ease the latest round of restrictions. But those with compromised immune systems and other disabilities fear they could pay the price.

This week’s panelists are Julie Rovner of KHN, Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico, and Rachel Cohrs of Stat.

Among the takeaways from this week’s episode:

  • The criticism seeping out about Becerra could signal frustration in the administration and on Capitol Hill that the country is still subject to so many pandemic-driven restraints and the public is looking for solutions.
  • Nonetheless, it appears that congressional Republicans — if they win a majority later this year in the midterm elections — could use this issue to press their contention that the administration has not been effective enough in the battle against covid.
  • The nomination of Dr. Robert Califf to head the FDA appears to be languishing in the Senate. Some Democrats are concerned that when he worked there before he wasn’t attuned to the growing dangers of the opioid epidemic, while others object to his ties to industry. Republicans, whom the administration was counting on to help push the nomination through, are under pressure to resist from their allies in the anti-abortion movement who charge that Califf will allow more flexibility for women seeking medication abortions.
  • The Department of Labor, armed with new enforcement authority, is investigating 30 health insurance plans for failing to abide by the requirements for insurance coverage parity for mental health. Congress has been trying to require equal treatment for mental and physical health since the mid-1990s, but so far it remains more of an aspiration.
  • A federal appeals court has allowed to stand, at least for now, a Tennessee law that bans abortions based on sex, race, or a Down syndrome diagnosis. An appeals court panel had temporarily halted the law, but the full appeals court overturned that decision and said it would wait to see what the Supreme Court decides this year in a Mississippi case that could change the landmark Roe v. Wade decision making abortion legal throughout the country.
  • Some experts have suggested that the decision years ago by doctors to move most abortions out of their offices and into specialized clinics has made the clinics an easy target and given groups opposed to the procedure an advantage in their fight. That might be countered by the increasing use of abortion pills that doctors can prescribe for women.
  • California lawmakers seeking to set up a state-funded health system, often called a single-payer system, this week conceded they didn’t have the votes to move forward. The proposal was hugely expensive and it would have had two major exemptions: people on Medicare and those covered by large companies that have plans regulated by the federal government.

Also this week, Rovner interviews KHN’s Noam N. Levey, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a very large bill for a very small amount of medical care. If you have an outrageous medical bill you’d like to share with us, you can do that here.

Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too:

Julie Rovner: The Washington Post’s “Researchers Are Asking Why Some Countries Were Better Prepared for Covid. One Surprising Answer: Trust,” by Adam Taylor

Alice Miranda Ollstein: Politico’s “Next Big Health Crisis: 15M People Could Lose Medicaid When Pandemic Ends,” by Megan Messerly

Margot Sanger-Katz: KHN’s “Faxes and Snail Mail: Will Pandemic-Era Flaws Unleash Improved Health Technology?” by Bram Sable-Smith

Rachel Cohrs: Stat’s “How a Decades-Old Database Became a Hugely Profitable Dossier on the Health of 270 Million Americans,” by Casey Ross

Also discussed on this week’s podcast:

The New York Times’ “In Medicine, a Lack of Courage Has Helped Put Roe in Jeopardy,” by Eyal Press

The New York Times’ “On Abortion Law, the U.S. Is Unusual. Without Roe, It Would Be, Too,” by Claire Cain Miller and Margot Sanger-Katz

The New York Times Magazine’s “The New Abortion Providers,” by Emily Bazelon

Mother Jones’ “Desperate Patients Are Shelling Out Thousands for a Long Covid Cure. Is It for Real?” by Kiera Butler




Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants. Image Credit: Studio Romantic/Shutterstock

Evaluating effectiveness of the COVID-19 mRNA-1273 vaccine against Omicron and Delta variants

by Medical Finance
May 20, 2022
0

In a study recently published on the medRxiv* pre-print server, a team of researchers investigated the effectiveness of one to...

(A) Schematic of the physical changes that take place when an airborne aqueous droplet equilibrates to the surrounding relative humidity. On the left (blue box) the particle is an aqueous homogenous sphere. As the particle equilibrates to a sub-saturated RH, low-solubility solutes can precipitate inclusions within the droplet (yellow box). At a sufficiently low RH, the dominant solute (NaCl) can crystallize causing the particle to effloresce (black box). (B) Schematic of the CELEBS technique. Virus-containing particles are levitated under controlled conditions and then deposited into media which is then plated onto a cell culture. By enumerating the cytopathic effect from that deposition, the amount of virus present can be quantified. (C) Schematic of the CK-EDB technique. Particles generated by the same droplet dispensers used in CELEBS are levitated under controlled conditions in the path of a laser. The physical changes that take place in that particle are studied through analysis of the light scattered by that particle.

Airborne decay of SARS-CoV-2 occurs within minutes

by Medical Finance
May 20, 2022
0

Understanding the factors that influence the airborne survival of viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in...

Study: SARS-CoV-2 Reverse Zoonoses to Pumas and Lions, South Africa. Image Credit: Evgeniyqw/Shutterstock

Study shows possible reverse zoonoses of SARS-CoV-2 from humans to animals

by Medical Finance
May 20, 2022
0

Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has been causing coronavirus disease (COVID-19), a pandemic that has been ruling our...

Study: Functional Status, Mood State, And Physical Activity Among Women with Post-Acute COVID-19 Syndrome. Image Credit: fizkes / Shutterstock.com

Effects of post-acute COVID-19 on physical and mental health in women

by Medical Finance
May 20, 2022
0

With more than 330 million documented cases of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide since the...

Study: Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant. Image Credit: Teeradej/Shutterstock

Study finds heterologous vaccine booster evokes robust immunity to SARS-CoV-2 Omicron variant

by Medical Finance
May 20, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in the last month of 2019 has undergone several...

Study: Egg-derived anti-SARS-CoV-2 immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19: preclinical studies and randomized controlled phase 1 clinical trial. Image Credit: NIAID

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

by Medical Finance
May 20, 2022
0

Coronavirus disease 2019 (COVID-19), caused by the rapid outbreak of severe acute respiratory disease coronavirus-2 (SARS-CoV-2), has claimed more than...

Next Post
Discovering new drug targets for neurodegenerative diseases

Discovering new drug targets for neurodegenerative diseases

Forging a new era in cancer treatment with CAR T-cell therapy

Forging a new era in cancer treatment with CAR T-cell therapy

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Image Credit:  PIC SNIPE/Shutterstock
    Three exposures to SARS-CoV-2 spike protein can induce robust neutralizing antibodies against variants
  • Protein 620x480
    Study sheds light on the conformational dynamics of SARS-CoV-1 and SARS-CoV-2 spike proteins
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply